Prednisone is NOT Indicated for Acute Sprains
Oral prednisone should not be used for routine acute musculoskeletal sprains, as there is no evidence supporting its efficacy for this indication, and the FDA labeling does not include sprains as an approved use. 1
FDA-Approved Indications
The FDA label for prednisone specifies approved musculoskeletal indications, which are limited to:
- Acute and subacute bursitis
- Acute nonspecific tenosynovitis
- Acute gouty arthritis
- Post-traumatic osteoarthritis
- Synovitis of osteoarthritis
- Epicondylitis 1
Notably, acute sprains are conspicuously absent from this list of approved indications. 1
Evidence Against Use in Musculoskeletal Injuries
Low Back Pain Studies (Most Relevant Proxy)
While no studies directly examine prednisone for sprains, research on acute musculoskeletal low back pain provides the closest evidence:
A 2014 randomized controlled trial of 50 mg prednisone daily for 5 days in ED patients with acute musculoskeletal low back pain from bending/twisting injuries found no benefit in pain reduction, functional status, or return to work. 2
Patients receiving prednisone actually sought additional medical treatment more frequently (40% vs 18%) compared to placebo. 2
Radiculopathy Studies Show Minimal Benefit
Even in acute sciatica with nerve root involvement (a more severe condition than a simple sprain):
A 2015 trial showed only modest functional improvement (6.4-point ODI improvement at 3 weeks) with a 15-day tapering course of prednisone, but no improvement in pain scores. 3
Adverse events were significantly more common in the prednisone group (49.2% vs 23.9%). 3
Potential Harms
Systemic corticosteroids carry risks even with short courses:
- Hyperglycemia and metabolic disturbances 1
- Adrenal suppression with HPA axis dysfunction 1
- Increased infection risk in certain contexts 4
- Gastrointestinal irritation requiring antacid prophylaxis with higher doses 1
Clinical Bottom Line
For an acute sprain, standard RICE therapy (rest, ice, compression, elevation) combined with NSAIDs and/or acetaminophen remains the evidence-based approach. The lack of FDA approval, absence of supporting evidence, and potential for adverse effects make prednisone an inappropriate choice for this indication. 1, 2
If a clinician were to consider corticosteroids despite this recommendation, intra-articular injection would be vastly preferable to systemic oral therapy for localized joint injuries, though this still lacks evidence for acute sprains specifically. 5